Primobolan 100 - Genetic Pharmaceuticals

Methenolone enanthate’s clinical popularity in Europe stemmed from its tolerability and low risk of virilization, especially in female patients. Marketed as Primobolan Depot by Schering, it was routinely used in therapies for aging-related muscle loss, anemia, and post-trauma recovery. The compound was one of few injectable agents suited for long-duration treatment with minimal endocrine disruption. Though phased out of many markets, it remains referenced in clinical literature for its mild yet effective anabolic action.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Primobolan 100 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.